Journal of In Silico & In Vitro Pharmacology

Abstract

Prevalence of ADHD in childhood and persistence of symptoms in adulthood. The history of the diagnosis, ADHD through the life cycle, the myths that surround ADHD will be discussed. The treatments available options available, the protocols used in UK, the NICE Guidelines, and the research discussed. 75% of children diagnosed with ADHD in childhood have symptoms that continue to cause morbidity in adulthood. How the symptom profile can change as the person grows and the brain matures. The characteristic problems seen in adults, who have ADHD. The impact on health systems and society in terms of financial implications will presented. What is different in treatment protocols in children and in adults. Stimulants, nonstimulant medications, the effects, side effects and compliance issues. Drugs used in past to treat ADHD and potential side effects and monitoring requirements. Comorbidity is frequently seen with alcohol and drugs. Mental illness can also co occur in forms of depression and anxiety. The causes and probable treatment options of these comorbidities will be presented. The executive function deficits associated with the diagnosis and the day-to-day difficulties that present themselves. The adaptations that might help with these issue so as to empower patients to take control of their diagnosis. Treatment options available and expected outcomes. Discussion of different stimulants, the pharmacology and side effect profile. We will discuss the basis of choosing a specific subgroup of medications and what to expect. Psychological aspects of treatment and how they need to be presented differently for somebody with ADHD will be presented.